Do [ Local approval procedures act as a brake on RCTs ]?
The approval procedures for multicentre clinical trials in the Netherlands demonstrate major differences. Processing times, documentation required and costs are unpredictable; greater uniformity is highly desirable in this context.
Clinical differences between primary and secondary SUD were small and do not support the distinction.